Skip to page body Patient Care Survivorship Research Cancer Types News Giving Community Partners Clinical Trials
UCLA's Jonsson Comprehensive Cancer Center
Take the Jonsson Cancer Center Site Survey

JCCC Member Directory

David Jeffrey Demanes, M.D.
David Jeffrey Demanes, M.D.

Specialty:

Brachytherapy – Radiation Oncology

General Information:

Gender:
Male
Language(s):
English

Affiliation(s):

Professor, Department of Radiation Oncology, Brachytherapy
Director, High Dose Rate (HDR) Brachytherapy program
Member, JCCC Cancer Molecular Imaging Program Area

Hospital Affiliation(s):

Ronald Reagan UCLA Medical Center
Santa Monica-UCLA Medical Center and Orthopaedic Hospital

Education:

Fellowship:
Radiation Oncology, Long Beach Memorial Medical Center, 1981 - 1981
Internal Medicine, UC San Francisco School of Medicine, 1979 - 1981
Residency:
Radiation Oncology, UCLA School of Medicine, 1976 - 1979
Internal Medicine, Veterans Affairs Greater Los Angeles Healthcare System, 1975 - 1976
Internship:
Internal Medicine, Kaiser Foundation Hospital, 1974 - 1975
Medical Degree:
M.D., UCLA School of Medicine, 1974

Certification(s):

Medical Board Certification(s):
Medical Oncology, American Board of Internal Medicine, 1981
Therapeutic Radiology, American Board of Radiology, 1979
Internal Medicine, American Board of Internal Medicine, 1978

Contact Information:

Phone:
(310) 206-2510 Patient appointments
(310) 794-0023 Office
Email:
Website:

Practice Information:

Clinical Interest(s):
Brachytherapy
Women’s Cancers
Genitourinary Oncology
Thoracic Oncology (Developing)

Scientific Interest(s):

Dr. Jeffrey Demanes’ scientific interests are clinical outcome studies for patients treated with brachytherapy, development of brachytherapy technical methods, and innovative applications for brachytherapy. His special area of expertise is high dose rate (HDR) brachytherapy.

Selected Cancer-Related Publications:

Demanes DJ, Martinez AA, Ghilezan M, Hill DR, Schour L, Brandt D, Gustafson G. High-dose-rate monotherapy: safe and effective brachytherapy for patients with localized prostate cancer. Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):1286-92. doi: 10.1016/j.ijrobp.2010.10.015. Epub 2011 Feb 9.

Demanes DJ, Brandt D, Schour L, Hill DR. Excellent results from high dose rate brachytherapy and external beam for prostate cancer are not improved by androgen deprivation. Am J Clin Oncol. 2009 Aug;32(4):342-7.

Demanes DJ, Rodriguez RR, Schour L, Brandt D, Altieri G. High-dose-rate intensity-modulated brachytherapy with external beam radiotherapy for prostate cancer: California endocurietherapy's 10-year results. Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1306-16. Review.

Demanes DJ, Samaranayake RP, Cmelak A, Cruz R, Rodriguez RR. Brachytherapy and External Radiation for Carcinoma of the Base of Tongue: Implantation of the Primary Tumor and Cervical Adenopathy. International Journal of Brachytherapy, 2000: 16:211-223.

Demanes DJ, Rodriguez RR, Bendre DD, Ewing TL. High dose rate transperineal interstitial brachytherapy for cervical cancer: high pelvic control and low complication rates. Int J Radiat Oncol Biol Phys. 1999 Aug 1;45(1):105-12.